TWiV 879: Indolent, resistant, and losing our TMPRSS
About this episode
TWiV reviews the emergence of remdesivir-resistant SARS-CoV-2 during treatment of a persistently infected immunocompromised patient, and how altered TMPRSS2 utilization by the Omicron variant influences infectivity and fusion.
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, Kathy Spindler, and Brianne Barker
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- ASV 2022
- Emergence of remdesivir resistance (Nature Comm)
- How to stall a copy machine (TWiV 819)
- Omicron altered TMPRSS2 usage (Nature)
- Timestamps by Jolene. Thanks!
Weekly Picks
Brianne – NSURP 2022
Kathy – Virology Jobs
Rich – 10 Steps from Seed to Cup (Graphic)
Alan – Fathoms: The World in The Whale, by Rebecca Giggs
Vincent – Worldwaterday.org
Listener Picks
Jeremy – Archaeology of Light
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology